Oncology
Fortrea brings extensive depth of expertise to oncology therapeutic development and our MDs and subject matter experts have helped bring many of today's precision medicines to market. Learn more here.
About Us
Raising CRO standards for innovation and delivery to help bring life-changing treatments to patients faster.
Advancing rare disease clinical trials and orphan drug research: A focus on APAC and China
Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions.
Prader-Willi Syndrome trials
Effective planning to address unmet needs in Prader-Willi Syndrome trials
Creating patient- and site-centric solutions for a challenging antibiotic study
A pharmaceutical company partnered with Fortrea to support their Phase 1b pharmacokinetic clinical trial of a new antibiotic candidate for life-threatening nosocomial infections, including drug-resistant infections.
The future of obesity research
Discussing the future of obesity research with Dr. Claudia Filozof and Dr. Eric Ravussin (23 min)
Achieving diversity in drug development programs for obesity
Diversity action plans
Anti-obesity drug development: advances, challenges and mitigations to maximize success
Advances, challenges and mitigation to maximize success